Please wait a minute...
Journal of ZheJiang University(Medical Science)  2015, Vol. 44 Issue (4): 357-360    DOI: 10.3785/j.issn.1008-9292.2015.07.01
    
Guidelines for diagnosis and management of aneurysmal subarachnoid hemorrhage: top issues and prospective
ZHANG Jian-min
Department of Neurosurgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Download:   PDF(663KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: Aneurysmal subarachnoid hemorrhage (aSAH) is a kind of hemorrhagic stroke with high mortality and morbidity. Although the preoperative diagnosis, surgical clipping, endovascular treatment, and intensive care have progressed in recent years, the overall prognosis of aSAH patients remains poor. In 2011, the Neurocritical Care Society organized an international, multidisciplinary consensus conference addressed the critical care management of SAH. In 2012, the American Stroke Association (AHA) updated the guidelines of diagnosis and treatment of aSAH published in 2009. In 2013, European Stroke Organization established the guideline for management of intracranial aneurysms and SAH. In 2014, the Korean Society of Interventional Neuroradiology (KSIN) published clinical practice guideline for the management of ruptured and unruptured aneurysms. The guideline for diagnosis and management of aSAH for Chinese patients has been drafted in this year. Thus, the diagnosis and management of aSAH is a hot topic in neurosurgery. This editorial summarizes the above mentioned guidelines and focuses on the progress and update of these guidelines. In this article we discuss the advantage and disadvantage of those imaging techniques, the pros and cons of surgical clipping and endovascular treatment.



Key wordsSubarachnoid hemorrhage/diagnosis      Subarachnoid hemorrhage/therapy      Review     
Received: 06 February 2015     
CLC:  R741  
Cite this article:

ZHANG Jian-min. Guidelines for diagnosis and management of aneurysmal subarachnoid hemorrhage: top issues and prospective. Journal of ZheJiang University(Medical Science), 2015, 44(4): 357-360.

URL:

http://www.zjujournals.com/xueshu/med/10.3785/j.issn.1008-9292.2015.07.01     OR     http://www.zjujournals.com/xueshu/med/Y2015/V44/I4/357


动脉瘤性蛛网膜下腔出血诊治热点问题及展望

动脉瘤性蛛网膜下腔出血(aSAH)是一类致死率和致残率极高的出血性脑卒中.尽管aSAH临床术前诊断、术中治疗和术后重症监护等方面都获得了很大的进展,但aSAH患者的总体预后并无明显改善.2011年,美国神经危重症协会发布了aSAH患者重症医学处理的推荐意见;2012年,心脏病协会和美国卒中协会更新了2009年aSAH的诊治指南;2013年,欧洲卒中组织制定了欧洲颅内动脉瘤和aSAH诊疗指南;2014年,韩国神经介入学会发布了破裂和未破裂动脉瘤的治疗指南.2015年,中国医师协会神经外科专家委员会也发布了重症aSAH管理专家共识.可见,aSAH的诊治成为神经外科研究的重点和热点.本文总结上述指南中关于aSAH诊断和治疗方面的重点内容、新进展或更新,比较各种用于aSAH诊断的影像学检查的优缺点,探讨手术治疗和血管内治疗的适应证,以期提高aSAH诊治水平,改善患者的预后.


关键词: 蛛网膜下腔出血/诊断,  蛛网膜下腔出血/治疗,  综述 
[[1]]   GARCIA-RODRIGUEZ L A, GAIST D, MORTON J, et al. Antithrombotic drugs and risk of hemorrhagic stroke in the general population [J]. Neurology, 2013,81(6):566-574.
[[2]]   DIRINGER M N, BLECK T P, CLAUDE HEMPHILL J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference [J]. Neurocrit Care, 2011,15(2):211-240.
[[3]]   CONNOLLY E S JR, RABINSTEIN A A, CARHUAPOMA JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2012,43(6):1711-1737.
[[4]]   STEINER T, JUVELA S, UNTERBERG A, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage [J]. Cerebrovasc Dis, 2013,35(2):93-112.
[[5]]   JEONG H W, SEO J H, KIM S T, et al. Clinical practice guideline for the management of intracranial aneurysms[J]. Neurointervention, 2014,9(2):63-71.
[[6]]   MACDONALD R L. Stroke: new guidelines for subarachnoid haemorrhage-required reading [J]. Nat Rev Neurol, 2012,8(8):418-419.
[[7]]   徐跃峤, 王 宁, 胡 锦,等. 重症动脉瘤性蛛网膜下腔出血管理专家共识(2015)[J]. 中国脑血管病杂志, 2015,12(4):215-224. XU Yue-qiao,WANG Ning,HU Jin,et al.International consensus on management of severe intracranial subarachnoid hemorrhage[J]. Chinese Journal of Cerebrovascular Diseases, 2015,12(4):215-224.(in Chinese)
[[8]]   PECHLIVANIS I, HARDERS A, TUTTENBERG J, et al. Computed tomographic angiography: diagnostic procedure of choice in the management of subarachnoid hemorrhage in the elderly patient?[J]. Cerebrovasc Dis, 2009,28(5):481-489.
[[9]]   KLEINLOOG R, KORKMAZ E, ZWANENBURG J J, et al. Visualization of the aneurysm wall: a 7.0-tesla magnetic resonance imaging study[J]. Neurosurgery, 2014,75(6):614-622.
[[10]]   BAHAROGLU M I, GERMANS M R, RINKEL G J, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage[J]. Cochrane Database Syst Rev, 2013,8: CD001245.
[[11]]   MOLYNEUX A J, BIRKS J, CLARKE A, et al. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT) [J]. Lancet, 2014,385(9969):691-697.
[1] GAO Siqian,SHEN Yongmei,GENG Funeng,Yanhua LI,Jianqing GAO. Temporal lobe epilepsy and adult hippocampal neurogenesis[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 97-105.
[2] WANG Ying,WANG Yi,CHEN Zhong. The role of central cholinergic system in epilepsy[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 15-21.
[3] GAO Siqian,SHEN Yongmei,GENG Funeng,LI Yanhua,GAO Jianqing. Research progress on the animal models and treatment strategies of diabetic foot ulcer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 97-105.
[4] LI Wenlong,QU Haibin. Application progress on near infrared spectroscopy in quality control and process monitoring of traditional Chinese medicine[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 80-88.
[5] ZHENG Yanrong,ZHANG Xiangnan,CHEN Zhong. Research progress on mechanism of Nix-mediated mitophagy[J]. Journal of ZheJiang University(Medical Science), 2017, 46(1): 92-96.
[6] FENG Sheng, CHEN Jijun, ZHENG Yichun. Research progress on the effect of glucocorticoid receptor signaling pathways in bladder cancer[J]. Journal of ZheJiang University(Medical Science), 2016, 45(6): 655-660.
[7] LI Tongyu, LIANG Ping. Research progress on disease models and gene therapy of Duchenne muscular dystrophy[J]. Journal of ZheJiang University(Medical Science), 2016, 45(6): 648-654.
[8] CAO Peng, LENG Dongjin, LI Ying, ZHANG Ziwei, LIU Lei, LI Xiaoyan. Progress on anti-tumor molecular mechanisms of dihydroartemisinin[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 501-507.
[9] LI Tingting, KE Yuehai, CHENG Hongqiang. Reasearch progress on the role of neutrophils in asthma[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 544-549.
[10] WANG Xue, ZHANG Yuchuan, CHEN Wei. Research progress on the role of TANK-binding kinase 1 in anti-virus innate immune response[J]. Journal of ZheJiang University(Medical Science), 2016, 45(5): 550-557.
[11] DU Miaomiao, MA Gaigai, SHI Yuping. Research progress on pharmacotherapy of calcific aortic valve disease[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 432-438.
[12] HE Bin, CHAI Yanlan, WANG Tao, ZHOU Zhenxing, LIU Zi. Progress on clinical application of bevacizumab for the treatment of refractory cervical cancer[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 395-402.
[13] LI Xueying, ZHU Lixia, YE Xiujin. Aberrant DNA methylation and its targeted therapy in acute myeloid leukemia[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 387-394.
[14] ZHU Tianhong, ZHANG Xinmei. Research progress on the role of epithelial-mesenchymal transition in pathogenesis of endometriosis[J]. Journal of ZheJiang University(Medical Science), 2016, 45(4): 439-445.
[15] XU Yulan, XUE Yadan, KANG Lijun. The effect of glial cells in the function and development of the nervous system in Caenorhabditis elegans[J]. Journal of ZheJiang University(Medical Science), 2016, 45(3): 315-322.